Effects of Epeleuton, a Novel Synthetic Second‐Generation n‐3 Fatty Acid, on Non‐Alcoholic Fatty Liver Disease, Triglycerides, Glycemic Control, and Cardiometabolic and Inflammatory Markers

Effects of Epeleuton, a Novel Synthetic Second‐Generation n‐3 Fatty Acid, on Non‐Alcoholic Fatty Liver Disease, Triglycerides, Glycemic Control, and Cardiometabolic and Inflammatory Markers

Background Epeleuton is 15‐hydroxy eicosapentaenoic acid ethyl ester, a second‐generation synthetic n‐3 fatty acid derivative of eicosapentaenoic acid. The primary objective was to assess the effect of epeleuton on markers of nonalcoholic fatty liver disease (NAFLD) with post hoc analyses of cardiom...

Full description

Bibliographic Details
Main Authors: John Climax, Philip N. Newsome, Moayed Hamza, Markus Weissbach, David Coughlan, Naveed Sattar, Darren K. McGuire, Deepak L. Bhatt
Format: Article
Language:English
Published: Wiley 2020-08-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
15‐HEPE
DS102
epeleuton
n‐3 fatty acid
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.119.016334

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.119.016334

Similar Items